Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PBTZ169 Safety, PK, and Food Effects in Healthy Volunteers
NCT04150224Phase 1Completed
- Sponsor
- Nearmedic Plus
- Start
- Jul 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of macozinone in Tuberculosis (TB) (6 cohorts), sponsored by Nearmedic Plus. Primary endpoints: Number of Adverse Events and Number of Subjects With AEs. Started Jul 2018; status: completed.
02
Drugs
macozinone
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT04150224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04150224.